cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
0.8600
-0.0370 (-4.12%)
Aug 1, 2025, 4:00 PM - Market closed
cbdMD Revenue
cbdMD had revenue of $4.75M in the quarter ending March 31, 2025, with 8.52% growth. This brings the company's revenue in the last twelve months to $19.59M, down -9.22% year-over-year. In the fiscal year ending September 30, 2024, cbdMD had annual revenue of $19.48M, down -19.35%.
Revenue (ttm)
$19.59M
Revenue Growth
-9.22%
P/S Ratio
0.03
Revenue / Employee
$466,503
Employees
42
Market Cap
7.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 19.48M | -4.67M | -19.35% |
| Sep 30, 2023 | 24.16M | -11.25M | -31.77% |
| Sep 30, 2022 | 35.40M | -9.08M | -20.41% |
| Sep 30, 2021 | 44.48M | 2.60M | 6.20% |
| Sep 30, 2020 | 41.88M | 18.23M | 77.09% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
YCBD News
- 5 weeks ago - cbdMD Expands Oasis Social Tonics to Total Wine - Newsfile Corp
- 2 months ago - Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia - Newsfile Corp
- 2 months ago - cbdMD, Inc. (YCBD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter - Newsfile Corp
- 3 months ago - cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results - Newsfile Corp
- 3 months ago - Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North Carolina - Newsfile Corp
- 3 months ago - Herbal Oasis Wins National Recognition at the 2025 High Spirits Awards - Newsfile Corp
- 3 months ago - cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion - Newsfile Corp